Chart-Typ:
Zeitraum:
| Jumia Technologies AG: Jumia to Announce First Quarter 2026 Results on May 7, 2026 | LAGOS, NIGERIA / ACCESS Newswire / April 27, 2026 / Jumia Technologies AG (NYSE:JMIA) ("Jumia") today announced that it will release results for the first quarter 2026 before the U.S. market opens on... ► Artikel lesen |
| EQS-HV: Jumia Technologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 15.05.2026 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: Jumia Technologies AG
/ Bekanntmachung der Einberufung zur Hauptversammlung
Jumia Technologies AG: Bekanntmachung der Einberufung zur Hauptversammlung am 15.05.2026... ► Artikel lesen |
| Jumia Technologies AG: Jumia Files Annual Report 2025 on Form 20-F with the U.S. Securities and Exchange Commission | BERLIN, GERMANY / ACCESS Newswire / February 24, 2026 / Jumia Technologies AG (NYSE:JMIA), the leading pan-African e-commerce platform, announced that it has filed its Annual Report on Form 20-F for... ► Artikel lesen |
| EQS-News: ABIVAX: Abivax to Present Data on Obefazimod at Digestive Disease Week | EQS-News: ABIVAX
/ Key word(s): Conference
Abivax to Present Data on Obefazimod at Digestive Disease Week
22.04.2026 / 22:05 CET/CEST
The issuer is solely responsible... ► Artikel lesen |
| EQS-News: ABIVAX: Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents | EQS-News: ABIVAX
/ Key word(s): AGM/EGM
Abivax Annual Ordinary and Extraordinary General Meeting of May 11, 2026 Availability of the Preparatory Documents
20.04.2026 /... ► Artikel lesen |
| EQS-News: ABIVAX: Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies | EQS-News: ABIVAX
/ Key word(s): Miscellaneous
Abivax Publishes Financial Reports with the French and U.S. Securities Regulatory Agencies
01.04.2026 / 22:05 CET/CEST
The... ► Artikel lesen |
| Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results | SEATTLE, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics... ► Artikel lesen |
| Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results | SEATTLE, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WESHOP HOLDINGS LIMITED finden Sie auf Wallstreet Online.